In the current study, we were, to our knowledge, the first to demonstrate that the overexpression of ASM sensitizes HCC cells for the administration of mitomycin by enhancing its antiproliferative effects (Figure 3). This evidence concerns the gene SMPD1 and hepatocellular carcinoma.